| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.49B | 42.76B | 37.06B | 33.14B | 30.26B | 31.56B |
| Gross Profit | 9.59B | 9.23B | 7.83B | 6.56B | 5.95B | 5.57B |
| EBITDA | 5.43B | 5.20B | 3.79B | 2.88B | 2.65B | 2.40B |
| Net Income | 3.56B | 3.38B | 2.42B | 1.83B | 1.58B | 1.42B |
Balance Sheet | ||||||
| Total Assets | 26.70B | 30.20B | 26.83B | 23.02B | 21.93B | 20.05B |
| Cash, Cash Equivalents and Short-Term Investments | 2.04B | 10.21B | 10.31B | 2.63B | 1.90B | 2.07B |
| Total Debt | 10.00M | 14.00M | 22.00M | 30.00M | 41.00M | 5.00M |
| Total Liabilities | 6.06B | 9.50B | 8.67B | 7.19B | 7.55B | 7.01B |
| Stockholders Equity | 19.13B | 19.17B | 16.75B | 14.57B | 13.22B | 11.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.86B | 3.42B | -771.00M | 2.30B | 717.00M |
| Operating Cash Flow | 0.00 | 3.02B | 4.09B | -430.00M | 2.45B | 806.00M |
| Investing Cash Flow | 0.00 | -2.10B | -2.76B | 1.25B | -2.32B | -1.22B |
| Financing Cash Flow | 0.00 | -939.00M | -899.00M | -526.00M | -420.00M | -381.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥7.35B | 5.20 | ― | 3.35% | 7.25% | -11.62% | |
75 Outperform | ¥68.72B | 11.93 | ― | 2.82% | -5.63% | 52.73% | |
68 Neutral | ¥110.59B | 9.68 | ― | 2.91% | 31.48% | 83.15% | |
67 Neutral | ¥15.02B | 5.69 | ― | 3.88% | 15.50% | ― | |
66 Neutral | ¥46.86B | 12.09 | ― | 2.70% | 17.96% | 30.46% | |
66 Neutral | ¥1.90T | 15.23 | ― | 1.59% | 14.45% | 29.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |